2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline

Shaanxi Cuikang Pharmaceutical Technology Co., Ltd., founded in January 2023, is a wholly-owned subsidiary of Shaanxi Cuicheng Bio-pharmaceutical Technology Co., Ltd., and a comprehensive innovative enterprise focusing on the research and development, production, sales, import and export trade, technical services and related resource allocation and integration of products in the field of fine chemistry and biochemistry. The company has built a 2700 square meter R&D center in Hanzhong, Shaanxi Province, and has established in-depth and stable cooperative relations with three factories, which can provide one-stop service for domestic and foreign customers from pilot R&D to industrial scale-up production.

Cuikang Company is an enterprise integrating natural products, fine chemicals, biological fermentation, innovative material research and development, production, sales and technical services. It can provide global customers with a series of products with different specifications and models, such as proportional plant extracts, content plant extracts, synthetic chemical blocks, synthetic pharmaceutical intermediates, active API molecules, fermented pharmaceutical intermediates and APIs, health food, functional food raw materials, veterinary drug raw materials, pharmaceutical innovative materials, laboratory equipment, pharmaceutical machinery and equipment.

The company adheres to the market demand-oriented, technical innovation as the starting point, product quality as the core, customer service as the foundation, and the enterprise spirit of "professional integrity", and wholeheartedly provides high-quality products and services for customers at home and abroad.